There was a greater reduction in major or clinically relevant nonmajor bleeding with apixaban compared with warfarin in East Asian ( HR @ , @ % CI @-@ @ ) than in non-East Asian ( HR @ , @ % CI @-@ @ ) patients ( interaction P = @ ) .